Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic relapsing disease in gastrointestinal tract. Conventional medications lack the efficacy to offer complete remission in IBD therapy, and usually associate with serious side effects. Recent studies indicated that nanoparticle-based nanotherapeutics may off...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Baishideng Publishing Group Inc
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016370/ |